
Fraxiparine 3800IU Injection
Marketer
Glaxo SmithKline Pharmaceuticals Ltd
Salt Composition
Nadroparin (3800IU)
Overview Fraxiparine 3800IU Injection
Nadroparin 3800 IU injection is an anticoagulant medication preventing and treating dangerous blood clots. It inhibits existing clot growth and formation of new clots in vital areas such as the legs, lungs, brain, and heart. Administration is strictly by a healthcare professional (doctor or nurse). Dosage and treatment duration are tailored to individual health status, treatment goals, response to therapy, age, and weight. Continued injections are crucial, even without symptoms, for ongoing clot prevention; discontinuation increases clot risk. Potential side effects include bleeding, injection site reactions, elevated liver enzymes, and injection site bruising. Patients should minimize activities increasing bleeding risk, exercising caution with sharp objects. Prior to use, disclose any history of hypertension, diabetes, or recent stroke. This medication is contraindicated in patients with active bleeding. Inform your physician of all other medications to ensure compatibility. Pregnant or breastfeeding individuals should consult their doctor before commencing treatment with Nadroparin 3800 IU.
Primary Ingredients of Fraxiparine 3800IU Injection
No text was provided to rewrite.
Uses of Fraxiparine 3800IU Injection
Preventing and managing blood clots
Major Benefits of Fraxiparine 3800IU Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Fraxiparine 3800IU Injection:
- Injection site reaction
- Bleeding
- Injection site hematoma
- Increased liver enzymes
How to use Fraxiparine 3800IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Fraxiparine 3800IU Injection works:
Sanofi's Fraxiparine 3800 IU injection is a medication used to prevent blood clots.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Fraxiparine 3800IU Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Fraxiparine 3800IU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Fraxiparine 3800IU Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Fraxiparine 3800IU Injection on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
Individuals with severe kidney impairment should use Fraxiparine 3800 IU Injection cautiously. Dosage modification of Fraxiparine 3800 IU Injection may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Fraxiparine 3800IU Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Fraxiparine 3800IU Injection :
Should you forget a Fraxiparine 3800IU Injection, seek your physician's advice.
Facts to Know About Fraxiparine 3800IU Injection
| Label | Value |
|---|---|
| Chemical Type | Low-molecular-weight heparin |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Actions | Low-molecular-weight heparin (LMWH) |
